Category: Diabetes

VA Studies Raise Key Issues about Trends in Type 2 Diabetes Treatment

VA Studies Raise Key Issues about Trends in Type 2 Diabetes Treatment

Early Insulin, Singular Focus on HbA1c Not Always Best By Brenda L. Mooney NASHVILLE — New VA research soon might change the way clinicians treat veterans with type 2 diabetes. Despite the increased push for early initiation of insulin in… Read More

Less Diabetes Control in Non-adherence HIV Patients

DURHAM, NC – Poor adherence to antiretroviral therapy in veterans with human immunodeficiency virus (HIV) also is a good predictor of whether those same patients will achieve good control if they have diabetes. That’s according to a study from the… Read More

Diagnosis Prompts Weight Loss Efforts in Short Term

DURHAM, NC – Patients may rush to start a weight loss program upon diagnosis of an obesity-related disease but often are unable to sustain the effort on that basis alone, according to a new VA study. The study, published recently… Read More

Surgery Means Better Glucose Control for Veterans

BRONX, NY – Laparoscopic sleeve gastrectomy produced better blood glucose control for veterans after two years than standard diabetes medical care without weight loss surgery, according to a new study. The research, presented recently at the joint meeting of the… Read More

New Biomarkers May Be More Accurate than HbA1c in Diabetes Screening

New Biomarkers May Be More Accurate than HbA1c in Diabetes Screening

Although widely used to monitor glucose control and — more recently — to diagnose diabetes, HbA1c screening lacks accuracy in a range of patients with hemoglobinopathies, kidney issues or HIV. A new study, supported by the VA, lays out the… Read More

Prostate Cancer Recurrence Risk Rises 50% with Elevated Glucose Levels

Prostate Cancer Recurrence Risk Rises 50% with Elevated Glucose Levels

By Annette M. Boyle SEATTLE — Obesity is clearly associated with poor outcomes in patients with prostate cancer, according to past research, but the reason why has remained elusive. Now a new study suggests the real culprit might be hyperglycemia,… Read More

Meeting Two Treatment Goals Significantly Reduces CVD Risk

NEW ORLEANS — Veterans with diabetes who met treatment goals for both HbA1c and LDL cholesterol significantly reduced their risk for microvascular complications, acute coronary syndromes, percutaneous coronary intervention and coronary artery bypass graft compared with those who met only… Read More

Group Appointments Improved Dyslipidemia in Diabetic Vets

DURHAM, NC — How effective are group medical appointments for improving dyslipidemia in veterans with uncontrolled diabetes and hypertension? A recent study led by researchers from the Center for Health Services Research in Primary Care at the Durham, NC, VAMC… Read More

Intensive BP-Lowering Didn’t Affect Cognitive Function in Diabetes

WINSTON-SALEM, NC — A decline in cognitive function, reduced brain volume and increased white matter lesions are all risks for patients with type 2 diabetes mellitus (T2DM), especially with high blood pressure and lipid levels. In light of that, a… Read More

Metformin Doesn’t Decrease Bladder Cancer in Diabetes Patients

By Brenda L. Mooney PHILADELPHIA – Use of metformin does not decrease the incidence of bladder cancer in patients with diabetes, according to a study looking at new users of drug therapies. The study, published recently in Diabetes Care, found… Read More

Military Sleep Disorders Raise Diabetes Risk

SEATTLE — Insomnia and other sleep disorders plaguing military servicemembers and veterans could be an independent risk factor for developing diabetes, not just a symptom of depression or post-traumatic stress disorder (PTSD), according to a new study. The study, led… Read More

VA Study Finds Mortality Greater with Some Diabetes Drugs

SEATTLE — How do oral hypoglycemic medications for type 2 diabetes affect overall mortality? Concerned that few studies had been done on the drugs’ comparative safety, researchers from the VA Puget Sound Health Care System in Seattle sought to answer… Read More

Arthroplasty for Younger Diabetics Predicted to Increase

DENVER — A new VA study raises the specter of growing demand for joint arthroplasty by younger patients with diabetes. The report, based on research conducted at the VA Eastern Colorado Health Care System in Denver and the VA Medical… Read More

Newly Available Drugs Promote Weight Loss, Reduce Progression to Diabetes

Newly Available Drugs Promote Weight Loss, Reduce Progression to Diabetes

BIRMINGHAM, AL — Two recently available drugs for long-term treatment of obesity helped patients lose 5% or more of their body weight over the course of a year, according to their VA criteria for use statements. The medications, a phentermine and topiramate extended-release combination (P/T) and lorcaserin, are the first new weight loss drugs to be launched in 13 years.

Emphasizing Tradition to Reduce Diabetes in American Indians/Alaska Natives

By Annette M. Boyle Judy Goforth Parker, PhD, RN TAHLEQUAH, OK – Fifty years ago, the Cherokee had no word for diabetes. Today, American Indians and Alaska Native (AI/AN) adults have 2.3 times the risk of developing diabetes, and AI/AN… Read More

Hypoglycemia Poses Risk for All Blood Glucose Levels in Diabetes

By Annette M. Boyle Candis Morello, PharmD SAN DIEGO — For the more than one million veterans with diabetes, recent research raises new concerns about the risks of severe low blood glucose levels or hypoglycemia. In clinical trials, hypoglycemia occurs… Read More

VA’s MOVE! Program Touted as Model for Combating Diabetes, Obesity

By Stephen Spotswood ATLANTA – Can lifestyle changes be achieved in a large-scale healthcare setting, with patients maintaining improvement over several years? An Emory University study of VA’s Managing Obesity and Overweight Veterans Everywhere! (MOVE!) program suggests that they can.… Read More

Concentrated Insulin Effective Alternative for Some Diabetic Veterans

TAMPA, FL – Because U-500 concentrated regular insulin is five times more concentrated (500 units/1 mL) than the more commonly prescribed U-100 insulin (100 units/1 mL), fewer injections are required, which may result in improved adherence and patient satisfaction. Researchers… Read More

VA’s E-Consultation Equals In-Person Endocrinologist Care

HOUSTON — To improve specialty care accessibility, the Michael E. DeBakey VAMC (MEDVAMC) in Houston began the Diabetes Mellitis Electronic Consultation Service (DMECS) to provide specialty recommendations about diabetes care to primary care physicians (PCPs). The E-consultation, which is done… Read More

Reasons for Poor Diabetes Control in Patients Receiving VA Care

ATLANTA — Poor diabetes control with HbA1c levels exceeding 9% is a common problem, even at the VA where 20% of all patients with diabetes fall into that category despite established care. Noting that “most poorly controlled patients improve on… Read More